Search Results
Antiplatelet Therapy in High Bleeding Risk Patients Following PCI, November 6, 2020
Onyx ONE: aspirin vs. P2Y12 after 1-month dual antiplatelet therapy for high bleeding risk patients
Angioplasty in High Bleeding Risk Patients - Strategies and Management
TCT Connect 2020: The XIENCE 90/28 Trials — Dr Roxana Mehran
Management of Atrial Fibrillation (AF) with ACS and/or Undergoing PCI
Ischemic benefit vs. hemorrhagic risk in the THALES dual antiplatelet therapy trial
Antithrombotic strategies after ACS in HBR patients - Prof. Mohammed Sobhy
High Bleeding Risk or High Ischemic Risk: Are we talking about the same patient?
High bleeding risk patients: from clinical evidence to routine practice - AsiaPCR/SingLIVE 2018
Cardio Journal Club: Guided vs Standard Antiplatelet Therapy in Patients undergoing PCI.
The Preparedness Of Clinicians For Their Future And DAPT Duration In Patients With CAD
Role of P2Y12 inhibitor therapy in ACS and after PCI: Twilight and ISAR-React 5